Cancer Therapeutics Market (By Application: Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, Others; By Treatment Type: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

Table Of Content

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Cancer Therapeutics
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Cancer Therapeutics Market By Application
     1.2.2.1. Global Cancer Therapeutics Market Revenue and Growth Rate Comparison By Application (2015-2026)
     1.2.2.2. Global Cancer Therapeutics Market Revenue Share By Application in 2018
     1.2.2.3. Blood Cancer
     1.2.2.4. Colorectal Cancer
     1.2.2.5. Prostate Cancer
     1.2.2.6. Breast Cancer
     1.2.2.7. Cervical Cancer
     1.2.2.8. Head and Neck Cancer
     1.2.2.9. Glioblastoma
     1.2.2.10. Malignant Meningioma
     1.2.2.11. Mesothelioma
     1.2.2.12. Melanoma
     1.2.2.13. Others
   1.2.3. Cancer Therapeutics Market By Treatment Type
     1.2.3.1. Global Cancer Therapeutics Market Revenue and Growth Rate Comparison By Treatment Type (2015-2026)
     1.2.3.2. Global Cancer Therapeutics Market Revenue Share By Treatment Type in 2018
     1.2.3.3. Chemotherapy
     1.2.3.4. Targeted Therapy
     1.2.3.5. Immunotherapy
     1.2.3.6. Hormonal Therapy
     1.2.3.7. Others
   1.2.4. Cancer Therapeutics Market By Geography
     1.2.4.1. Global Cancer Therapeutics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
     1.2.4.2. North America Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)
     1.2.4.3. Europe Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)
     1.2.4.4. Asia-Pacific Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)
     1.2.4.5. Latin America Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)
     1.2.4.6. Middle East and Africa (MEA) Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Cancer Therapeutics Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Cancer Therapeutics Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Cancer Therapeutics Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Cancer Therapeutics Major Manufacturers in 2018

CHAPTER 4. CANCER THERAPEUTICS MARKET BY APPLICATION
4.1. Global Cancer Therapeutics Revenue By Application
4.2. Blood Cancer
   4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Lung Cancer
   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Colorectal Cancer
   4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Prostate Cancer
   4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Breast Cancer
   4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Cervical Cancer
   4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.8. Head and Neck Cancer
   4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.9. Glioblastoma
   4.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.10. Malignant Meningioma
   4.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.11. Mesothelioma
   4.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.12. Melanoma
   4.12.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.12.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.13. Others
   4.13.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.13.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. CANCER THERAPEUTICS MARKET BY TREATMENT TYPE
5.1. Global Cancer Therapeutics Revenue By Treatment Type
5.2. Chemotherapy
   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Targeted Therapy
   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Immunotherapy
   5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Hormonal Therapy
   5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Others
   5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA CANCER THERAPEUTICS MARKET BY COUNTRY
6.1. North America Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
   6.3.1. U.S. Cancer Therapeutics Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   6.3.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
6.4. Canada
   6.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   6.4.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE CANCER THERAPEUTICS MARKET BY COUNTRY
7.1. Europe Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
   7.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   7.3.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
7.4. Germany
   7.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   7.4.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
7.5. France
   7.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   7.5.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
7.6. Spain
   7.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   7.6.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
7.7. Rest of Europe
   7.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   7.7.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC CANCER THERAPEUTICS MARKET BY COUNTRY
8.1. Asia-Pacific Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
   8.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.3.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
8.4. Japan
   8.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.4.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
8.5. India
   8.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.5.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
8.6. Australia
   8.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.6.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
8.7. South Korea
   8.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.7.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
   8.8.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.8.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA CANCER THERAPEUTICS MARKET BY COUNTRY
9.1. Latin America Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
   9.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.3.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
9.4. Mexico
   9.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.4.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
9.5. Rest of Latin America
   9.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.5.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST & AFRICA CANCER THERAPEUTICS MARKET BY COUNTRY
10.1. Middle East & Africa Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East & Africa Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. GCC
   10.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   10.3.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
10.4. South Africa
   10.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   10.4.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)
10.5. Rest of Middle East & Africa
   10.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   10.5.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE
11.1. AbbVie Inc.
   11.1.1. Company Snapshot
   11.1.2. Overview
   11.1.3. Financial Overview
   11.1.4. Product Portfolio
   11.1.5. Key Developments
   11.1.6. Strategies
11.2. Astellas Pharma Inc.
   11.2.1. Company Snapshot
   11.2.2. Overview
   11.2.3. Financial Overview
   11.2.4. Product Portfolio
   11.2.5. Key Developments
   11.2.6. Strategies
11.3. Bristol Myers Squibb Company
   11.3.1. Company Snapshot
   11.3.2. Overview
   11.3.3. Financial Overview
   11.3.4. Product Portfolio
   11.3.5. Key Developments
   11.3.6. Strategies
11.4. Celgene Corporation
   11.4.1. Company Snapshot
   11.4.2. Overview
   11.4.3. Financial Overview
   11.4.4. Product Portfolio
   11.4.5. Key Developments
   11.4.6. Strategies
11.5. Eli Lilly and Company
   11.5.1. Company Snapshot
   11.5.2. Overview
   11.5.3. Financial Overview
   11.5.4. Product Portfolio
   11.5.5. Key Developments
   11.5.6. Strategies
11.6. F. Hoffmann-La Roche Ltd.
   11.6.1. Company Snapshot
   11.6.2. Overview
   11.6.3. Financial Overview
   11.6.4. Product Portfolio
   11.6.5. Key Developments
   11.6.6. Strategies
11.7. Johnson & Johnson
   11.7.1. Company Snapshot
   11.7.2. Overview
   11.7.3. Financial Overview
   11.7.4. Product Portfolio
   11.7.5. Key Developments
   11.7.6. Strategies
11.8. Merck & Co., Inc.
   11.8.1. Company Snapshot
   11.8.2. Overview
   11.8.3. Financial Overview
   11.8.4. Product Portfolio
   11.8.5. Key Developments
   11.8.6. Strategies
11.9. Novartis AG
   11.9.1. Company Snapshot
   11.9.2. Overview
   11.9.3. Financial Overview
   11.9.4. Product Portfolio
   11.9.5. Key Developments
   11.9.6. Strategies
11.10. Pfizer Inc.
   11.10.1. Company Snapshot
   11.10.2. Overview
   11.10.3. Financial Overview
   11.10.4. Product Portfolio
   11.10.5. Key Developments
   11.10.6. Strategies
11.11. Others
   11.11.1. Company Snapshot
   11.11.2. Overview
   11.11.3. Financial Overview
   11.11.4. Product Portfolio
   11.11.5. Key Developments
   11.11.6. Strategies

CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
   12.1.1. Initial Data Search
   12.1.2. Secondary Research
   12.1.3. Primary Research
12.2. Assumptions and Scope